PortfoliosLab logo

Aridis Pharmaceuticals, Inc. (ARDS)

Equity · Currency in USD · Last updated Sep 24, 2022

Company Info

ISINUS0403341045
CUSIP040334104
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$1.47
Year Range$0.91 - $3.81
EMA (50)$1.64
EMA (200)$1.95
Average Volume$141.77K
Market Capitalization$25.49M

ARDSShare Price Chart


Chart placeholderClick Calculate to get results

ARDSPerformance

The chart shows the growth of $10,000 invested in Aridis Pharmaceuticals, Inc. in Aug 2018 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $931 for a total return of roughly -90.69%. All prices are adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%AprilMayJuneJulyAugustSeptember
-29.63%
-19.28%
ARDS (Aridis Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ARDSReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-15.38%-10.55%
6M-31.25%-18.29%
YTD-48.07%-22.51%
1Y-67.65%-15.98%
5Y-44.35%7.18%
10Y-44.35%7.18%

ARDSMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-22.32%10.50%-12.00%-28.98%-8.00%-4.35%124.55%-40.89%-17.12%
202115.65%-10.11%-6.50%5.59%-7.22%28.03%-32.57%-19.44%-8.46%-4.89%-35.43%3.10%
202055.28%-2.46%-14.39%10.92%8.59%-4.60%5.58%-0.00%1.14%-12.57%10.50%-11.26%
2019-24.62%3.83%31.34%-22.72%-1.25%16.90%-14.45%34.25%-42.38%-24.91%8.84%-19.09%
20183.46%-2.94%-5.78%-13.82%4.62%

ARDSSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aridis Pharmaceuticals, Inc. Sharpe ratio is -0.61. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00AprilMayJuneJulyAugustSeptember
-0.61
-0.78
ARDS (Aridis Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ARDSDividend History


Aridis Pharmaceuticals, Inc. doesn't pay dividends

ARDSDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-91.16%
-23.00%
ARDS (Aridis Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ARDSWorst Drawdowns

The table below shows the maximum drawdowns of the Aridis Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aridis Pharmaceuticals, Inc. is 93.35%, recorded on May 12, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-93.35%Sep 5, 2018915May 12, 2022
-1.47%Aug 31, 20181Aug 31, 20181Sep 4, 20182
-1.15%Aug 15, 20184Aug 20, 20183Aug 23, 20187

ARDSVolatility Chart

Current Aridis Pharmaceuticals, Inc. volatility is 115.70%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%AprilMayJuneJulyAugustSeptember
115.70%
23.28%
ARDS (Aridis Pharmaceuticals, Inc.)
Benchmark (^GSPC)